Skip to main content
Erschienen in: Clinical Pharmacokinetics 2/2003

01.02.2003 | Original Research Article

Assessment of Markov-Dependent Stochastic Models for Drug Administration Compliance

verfasst von: Diane Wong, Reshma Modi, Dr Murali Ramanathan

Erschienen in: Clinical Pharmacokinetics | Ausgabe 2/2003

Einloggen, um Zugang zu erhalten

Abstract

Objective: There are few analytical results that describe patient compliance with drug administration regimens. The purpose of this paper is to develop and assess stochastic approaches for mathematical modelling of patient compliance with administration regimens.
Methods: Two stochastic models based on Markov-dependent random variables and on the Ising model were assessed for their ability to describe the variable nature of drug compliance.
Results: Both models use only experimentally accessible data, and their predictions were tested against published clinical compliance data obtained from electronic monitoring devices. The models satisfactorily fitted administration interval distribution data from several patients treated with diltiazem, a calcium channel antagonist, or zidovudine, an antiretroviral agent. The Ising model provides additional analytical expressions for the distribution of success runs and ‘drug holidays’ in administration regimens. These distribution predictions were tested with success run data for diltiazem and drug holiday data for two nonsteroidal anti-inflammatory drugs, piroxicam and tenoxicam.
Conclusion: Stochastic models can provide useful insights into drug compliance, and can be used to identify the administration patterns that are more likely to occur during drug self-administration in populations.
Literatur
1.
Zurück zum Zitat Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: 3273–7PubMedCrossRef Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: 3273–7PubMedCrossRef
2.
Zurück zum Zitat Urquhart J. Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens. Pharmacoeconomics 1999; 15: 217–28PubMedCrossRef Urquhart J. Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens. Pharmacoeconomics 1999; 15: 217–28PubMedCrossRef
3.
Zurück zum Zitat Sheiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther 1995; 57: 6–15PubMedCrossRef Sheiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther 1995; 57: 6–15PubMedCrossRef
4.
Zurück zum Zitat Efron B, Feldman D. Compliance as an explanatory variable in clinical trials. J Am Stat Assoc 1991; 86: 9–17CrossRef Efron B, Feldman D. Compliance as an explanatory variable in clinical trials. J Am Stat Assoc 1991; 86: 9–17CrossRef
5.
Zurück zum Zitat Levy G. A pharmacokinetic perspective on medicament non-compliance. Clin Pharmacol Ther 1993; 54: 242–4PubMedCrossRef Levy G. A pharmacokinetic perspective on medicament non-compliance. Clin Pharmacol Ther 1993; 54: 242–4PubMedCrossRef
6.
Zurück zum Zitat Nony P, Cucherat M, Boissel JP. Revisiting the effect compartment through timing errors in drug administration. Trends Pharmacol Sci 1998; 19: 49–54PubMedCrossRef Nony P, Cucherat M, Boissel JP. Revisiting the effect compartment through timing errors in drug administration. Trends Pharmacol Sci 1998; 19: 49–54PubMedCrossRef
7.
Zurück zum Zitat Taylor HM, Karlin S. An introduction to stochastic modeling. San Diego (CA): Academic Press, 1998: 631 Taylor HM, Karlin S. An introduction to stochastic modeling. San Diego (CA): Academic Press, 1998: 631
8.
Zurück zum Zitat Poland D, Scheraga HA. Theory of helix-coil transitions in bio-polymers. New York: Academic Press, 1970: xvii Poland D, Scheraga HA. Theory of helix-coil transitions in bio-polymers. New York: Academic Press, 1970: xvii
9.
Zurück zum Zitat Cantor CR, Schimmel PR. Biophysical chemistry. San Francisco (CA): W.H. Freeman, 1980 Cantor CR, Schimmel PR. Biophysical chemistry. San Francisco (CA): W.H. Freeman, 1980
10.
Zurück zum Zitat Evans M, Hastings N, Peacock B. Statistical distributions. New York: John Wiley & Sons Inc., 1993: 170 Evans M, Hastings N, Peacock B. Statistical distributions. New York: John Wiley & Sons Inc., 1993: 170
11.
Zurück zum Zitat Nelson R. Probability, stochastic processes and queueing theory: the maintenance of computer performance modeling. New York: Springer-Verlag, 1995: 583 Nelson R. Probability, stochastic processes and queueing theory: the maintenance of computer performance modeling. New York: Springer-Verlag, 1995: 583
12.
Zurück zum Zitat Rubio A, Cox C, Weintraub M. Prediction of diltiazem plasma concentration curves from limited measurements using compliance data. Clin Pharmacokinet 1992; 22: 238–46PubMedCrossRef Rubio A, Cox C, Weintraub M. Prediction of diltiazem plasma concentration curves from limited measurements using compliance data. Clin Pharmacokinet 1992; 22: 238–46PubMedCrossRef
13.
Zurück zum Zitat Girard P, Blaschke TF, Kastrissios H, et al. A Markov mixed effect regression model for drug compliance. Stat Med 1998; 17: 2313–33PubMedCrossRef Girard P, Blaschke TF, Kastrissios H, et al. A Markov mixed effect regression model for drug compliance. Stat Med 1998; 17: 2313–33PubMedCrossRef
14.
Zurück zum Zitat de Klerk E, van der Linden S, van der Heijde D, et al. Facilitated analysis of data on drug regimen compliance. Stat Med 1997; 16: 1653–64PubMedCrossRef de Klerk E, van der Linden S, van der Heijde D, et al. Facilitated analysis of data on drug regimen compliance. Stat Med 1997; 16: 1653–64PubMedCrossRef
15.
Zurück zum Zitat D’Argenio DZ, Schumitzky A. A program package for simulation and parameter estimation in pharmacokinetics. Comput Programs Biomed 1979; 9: 115–34PubMedCrossRef D’Argenio DZ, Schumitzky A. A program package for simulation and parameter estimation in pharmacokinetics. Comput Programs Biomed 1979; 9: 115–34PubMedCrossRef
16.
Zurück zum Zitat D’Argenio DZ, Schumitzky A. Adapt II users guide: pharmacokinetic/pharmacdynamic systems analysis software. Los Angeles (CA): Biomedical Simulations Resource, University of Southern California, 1997 D’Argenio DZ, Schumitzky A. Adapt II users guide: pharmacokinetic/pharmacdynamic systems analysis software. Los Angeles (CA): Biomedical Simulations Resource, University of Southern California, 1997
17.
Zurück zum Zitat Meyer UA, Peck CC. The drug holiday pattern of noncompliance in clinical trials: challenge to conventional concepts of drug safety and efficacy. Washington, DC: Center for Drug Development Science, Georgetown University, 1997 Meyer UA, Peck CC. The drug holiday pattern of noncompliance in clinical trials: challenge to conventional concepts of drug safety and efficacy. Washington, DC: Center for Drug Development Science, Georgetown University, 1997
18.
Zurück zum Zitat Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J 1992; 68 Suppl. 3: S49–58PubMed Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J 1992; 68 Suppl. 3: S49–58PubMed
19.
Zurück zum Zitat Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997; 20: 1512–7PubMedCrossRef Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997; 20: 1512–7PubMedCrossRef
Metadaten
Titel
Assessment of Markov-Dependent Stochastic Models for Drug Administration Compliance
verfasst von
Diane Wong
Reshma Modi
Dr Murali Ramanathan
Publikationsdatum
01.02.2003
Verlag
Springer International Publishing
Erschienen in
Clinical Pharmacokinetics / Ausgabe 2/2003
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926
DOI
https://doi.org/10.2165/00003088-200342020-00006

Weitere Artikel der Ausgabe 2/2003

Clinical Pharmacokinetics 2/2003 Zur Ausgabe